A share price of Impact BioMedical Inc [IBO] is currently trading at $0.51, down -9.19%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The IBO shares have gain 15.91% over the last week, with a monthly amount glided 18.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Impact BioMedical Inc experienced fluctuations in its stock price throughout the past year between $0.36 and $6.17. Impact BioMedical Inc [AMEX: IBO] shares were valued at $0.51 at the most recent close of the market.
Analyzing the IBO fundamentals
Gross Profit Margin for this corporation currently stands at -121.0% with Operating Profit Margin at -4217.29%, Pretax Profit Margin comes in at -5498.43%, and Net Profit Margin reading is -5496.29%. To continue investigating profitability, this company’s Return on Assets is posted at -2.02, Equity is -5.29 and Total Capital is 7.18. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -2.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4823 points at the first support level, and at 0.4544 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5414, and for the 2nd resistance point, it is at 0.5726.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Impact BioMedical Inc [AMEX:IBO] is 0.04. Also, the Quick Ratio is 0.02, while the Cash Ratio stands at 0.03. Considering the valuation of this stock, the price to sales ratio is 207.27.
Transactions by insiders
Recent insider trading involved DSS, INC., 10% Owner, that happened on May 22 ’25 when 0.12 million shares were sold. 10% Owner, DSS, INC. completed a deal on May 27 ’25 to sell 45400.0 shares. Meanwhile, 10% Owner DSS, INC. sold 0.89 million shares on Apr 04 ’25.
